Non-eligibility for reperfusion therapy in patients presenting with ST-segment elevation myocardial infarction: Contemporary insights from the National Cardiovascular Data Registry (NCDR)
- 24 October 2015
- journal article
- research article
- Published by Elsevier BV in American Heart Journal
- Vol. 172, 1-8
- https://doi.org/10.1016/j.ahj.2015.10.014
Abstract
No abstract availableThis publication has 20 references indexed in Scilit:
- Executive Summary: Heart Disease and Stroke Statistics—2015 UpdateCirculation, 2015
- 2013 ACCF/AHA Guideline for the Management of ST-Elevation Myocardial InfarctionJournal of the American College of Cardiology, 2012
- Recent Trends in the Incidence, Treatment, and Outcomes of Patients with STEMI and NSTEMIThe American Journal of Medicine, 2011
- Treatments, Trends, and Outcomes of Acute Myocardial Infarction and Percutaneous Coronary InterventionJournal of the American College of Cardiology, 2010
- Trends in reperfusion strategies, door-to-needle and door-to-balloon times, and in-hospital mortality among patients with ST-segment elevation myocardial infarction enrolled in the National Registry of Myocardial Infarction from 1990 to 2006American Heart Journal, 2008
- An Organized Approach to Improvement in Guideline Adherence for Acute Myocardial InfarctionJAMA Internal Medicine, 2008
- Trends in acute reperfusion therapy for ST-segment elevation myocardial infarction from 1999 to 2006: we are getting better but we have got a long way to goEuropean Heart Journal, 2008
- Decline in Rates of Death and Heart Failure in Acute Coronary Syndromes, 1999-2006JAMA, 2007
- The second Euro Heart Survey on acute coronary syndromes: characteristics, treatment, and outcome of patients with ACS in Europe and the Mediterranean Basin in 2004European Heart Journal, 2006
- Effects of Fondaparinux on Mortality and Reinfarction in Patients With Acute ST-Segment Elevation Myocardial Infarction: The OASIS-6 Randomized TrialJAMA, 2006